123 related articles for article (PubMed ID: 17459340)
1. Cell cycle effect on the activity of deoxynucleoside analogue metabolising enzymes.
Fyrberg A; Albertioni F; Lotfi K
Biochem Biophys Res Commun; 2007 Jun; 357(4):847-53. PubMed ID: 17459340
[TBL] [Abstract][Full Text] [Related]
2. The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia.
Lotfi K; Karlsson K; Fyrberg A; Juliusson G; Jonsson V; Peterson C; Eriksson S; Albertioni F
Biochem Pharmacol; 2006 Mar; 71(6):882-90. PubMed ID: 16436271
[TBL] [Abstract][Full Text] [Related]
3. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
[TBL] [Abstract][Full Text] [Related]
4. Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity.
Lotfi K; Månsson E; Peterson C; Eriksson S; Albertioni F
Biochem Biophys Res Commun; 2002 May; 293(5):1489-96. PubMed ID: 12054684
[TBL] [Abstract][Full Text] [Related]
5. Activity profiles of deoxynucleoside kinases and 5'-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs.
Rylova SN; Albertioni F; Flygh G; Eriksson S
Biochem Pharmacol; 2005 Mar; 69(6):951-60. PubMed ID: 15748706
[TBL] [Abstract][Full Text] [Related]
6. RNAi depletion of deoxycytidine and deoxyguanosine kinase in human leukemic CEM cells.
Fyrberg A; Albertioni F; Lotfi K
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):712-9. PubMed ID: 18600530
[TBL] [Abstract][Full Text] [Related]
7. Acute cytotoxicity of arabinofuranosyl nucleoside analogs is not dependent on mitochondrial DNA.
Curbo S; Johansson M; Balzarini J; Lewis LD; Karlsson A
Exp Cell Res; 2009 Sep; 315(15):2539-43. PubMed ID: 19481540
[TBL] [Abstract][Full Text] [Related]
8. Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5'-nucleotidase mRNA measurement in cell lines and in patients with leukemia.
Månsson E; Liliemark E; Söderhäll S; Gustafsson G; Eriksson S; Albertioni F
Leukemia; 2002 Mar; 16(3):386-92. PubMed ID: 11896543
[TBL] [Abstract][Full Text] [Related]
9. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
Hapke DM; Stegmann AP; Mitchell BS
Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309
[TBL] [Abstract][Full Text] [Related]
10. Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells.
Smal C; Cardoen S; Bertrand L; Delacauw A; Ferrant A; Van den Berghe G; Van Den Neste E; Bontemps F
Biochem Pharmacol; 2004 Jul; 68(1):95-103. PubMed ID: 15183121
[TBL] [Abstract][Full Text] [Related]
11. Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF.
Csapó Z; Sasvári-Székely M; Spasokoukotskaja T; Staub M
Acta Biochim Pol; 2001; 48(1):251-6. PubMed ID: 11440177
[TBL] [Abstract][Full Text] [Related]
12. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
[TBL] [Abstract][Full Text] [Related]
13. Expression of deoxynucleoside kinases and 5'-nucleotidases in mouse tissues: implications for mitochondrial toxicity.
Rylova SN; Mirzaee S; Albertioni F; Eriksson S
Biochem Pharmacol; 2007 Jun; 74(1):169-75. PubMed ID: 17493587
[TBL] [Abstract][Full Text] [Related]
14. [Special function of deoxycytidine kinase (dCK) in the activation of chemotherapeutic nucleoside analogs and in the inhibition of cell proliferation].
Staub M
Magy Onkol; 2004; 48(3):229-34. PubMed ID: 15520873
[TBL] [Abstract][Full Text] [Related]
15. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
Verhoef V; Sarup J; Fridland A
Cancer Res; 1981 Nov; 41(11 Pt 1):4478-83. PubMed ID: 6272978
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
[TBL] [Abstract][Full Text] [Related]
17. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase.
Zhu C; Johansson M; Permert J; Karlsson A
Biochem Pharmacol; 1998 Oct; 56(8):1035-40. PubMed ID: 9776315
[TBL] [Abstract][Full Text] [Related]
19. Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells.
Ohta T; Hori H; Ogawa M; Miyahara M; Kawasaki H; Taniguchi N; Komada Y
Oncol Rep; 2004 Nov; 12(5):1115-20. PubMed ID: 15492802
[TBL] [Abstract][Full Text] [Related]
20. The enantioselectivity of the cellular deoxynucleoside kinases.
Wang J; Chattopadhyaya J; Eriksson S
Nucleosides Nucleotides; 1999; 18(4-5):807-10. PubMed ID: 10432682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
